Clearfield (NASDAQ: CLFD) insider transactions
In the twelve months to 10 November 2026, executives and directors of Clearfield reported 8 open-market sales of 26,948 shares ($1.2m) and 1 open-market purchase of 10,000 shares ($300,600), by 5 people, according to the Form 4 filings they submitted to the SEC.
Latest transactions
| Date | Insider | Role | Transaction | Shares | Price | Held after | Filing |
|---|---|---|---|---|---|---|---|
| 1 July 2026 | Beranek Cheryl | Chief Executive Officer | Open-market sale, 10b5-1 plan | −1,778 | $40.06 | 492,973 | Form 4 |
| 30 June 2026 | Beranek Cheryl | Chief Executive Officer | Grant or award | +210 | $24.78 | 494,751 | Form 4 |
| 30 June 2026 | Hill John P | Chief Operating Officer | Grant or award | +459 | $24.78 | 192,674 | Form 4 |
| 30 June 2026 | Khemakhem Anis | Chief Commercial Officer | Grant or award | +158 | $24.78 | 25,284 | Form 4 |
| 30 June 2026 | Herzog Daniel R | Chief Financial Officer | Grant or award | +752 | $24.78 | 85,834 | Form 4 |
| 9 June 2026 | Khemakhem Anis | Chief Commercial Officer | Open-market sale | −1,684 | $39.90 | 25,126 | Form 4 |
| 1 June 2026 | Beranek Cheryl | Chief Executive Officer | Open-market sale, 10b5-1 plan | −7,500 | $46.92 | 494,541 | Form 4 |
| 27 May 2026 | Beranek Cheryl | Chief Executive Officer | Open-market sale, 10b5-1 plan | −2,500 | $50.00 | 502,041 | Form 4 |
| 11 May 2026 | Jones Walter Louis JR | Director | Open-market sale | −2,391 | $46.05 | 8,682 | Form 4 |
| 11 May 2026 | Beranek Cheryl | Chief Executive Officer | Open-market sale, 10b5-1 plan | −2,500 | $45.02 | 504,541 | Form 4 |
| 8 May 2026 | Beranek Cheryl | Chief Executive Officer | Open-market sale, 10b5-1 plan | −5,000 | $40.27 | 507,041 | Form 4 |
| 6 May 2026 | Khemakhem Anis | Chief Commercial Officer | Shares withheld for tax | −635 | $30.28 | 26,810 | Form 4 |
| 27 February 2026 | Seidel Rebecca | Director | Grant or award | +2,544 | — | 2,870 | Form 4 |
| 27 February 2026 | Roth Ronald G | Director | Grant or award | +2,544 | — | 1,281,808 | Form 4 |
| 27 February 2026 | Skarvan Kathleen | Director | Grant or award | +2,544 | — | 2,870 | Form 4 |
| 27 February 2026 | Sarcevic Ademir | Director | Grant or award | +2,544 | — | 5,317 | Form 4 |
| 27 February 2026 | Jones Walter Louis JR | Director | Grant or award | +2,544 | — | 11,073 | Form 4 |
| 27 February 2026 | Kelly Catherine T. | Director | Grant or award | +2,544 | — | 5,317 | Form 4 |
| 27 February 2026 | Wirsbinski Carol Ann | Director | Grant or award | +2,544 | — | 9,631 | Form 4 |
| 19 February 2026 | Hayward Donald R. | Director | Open-market sale | −3,595 | $32.00 | 10,870 | Form 4 |
Names appear as in the filing, surname first. A dash in the price column means the filing reports none, as in grants and gifts.
How to read the table
Only open-market purchases and sales are trades the insider chose to make at the market price, and they are the ones counted in the summary above. Grants, option exercises and shares withheld for tax come from pay plans. A sale marked as a 10b5-1 plan was scheduled in advance under a written plan.
Where each row comes from
From the Form 4 that each executive, director or large shareholder must file with the SEC within two business days of a transaction, read up to 10 November 2026. Each row links to its filing on EDGAR. Only transactions in shares are listed, not derivatives, and amended filings are left out. The accounts of the company are on the Clearfield page; the method, in data sources.
Information prepared from the Form 4 filings submitted to the SEC, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.